Breast augmentation
Breast enlargement is achieved by positioning an implant behind
the breast. The implant can be placed directly behind the breast
tissue or under the chest wall muscle. The surgical incision can be
placed in the fold under the breast, around the areola or in the
armpit. There is a range of implants available to suit different
situations. They all have an outer layer of silicone and can be
filled with either silicone gel or saline.

Capsular contracture - The breast tissue around the implant can
react by thickening and hardening as it treats the prosthesis as a
foreign body and tries to wall it off. This causes pain and changes
the shape of the breast as the implant is distorted by the capsular
tissue. the capsule can be broken down by the surgeon by applying
firm pressure. This is called a closed capsulotomy. In severe
cases the capsule has to be excised and the implant
replaced.
Migration - The implant can move from it's
original position resulting in a change in the shape of the breast.
This problem will require further surgery to reposition the
prosthesis.
Infection - the tissue around the implant can
become infected. Response to antibiotics may be slow and
occasionally the implant has to be removed to allow the tissue to
heal properly.
Rupture - The lining of the implant can burst
allowing silicone gel to ooze into the breast tissue. This can
cause tender lumps in the breast called silicone granulomas.The
implant will have to be removed or replaced.
Assessing breast problems in women with implants
The number of women with breast implants is increasing rapidly. In
Australia it is estimated that 6000 breast augmentation procedures
are performed annually. In addition approximately 3000 women
undergo removal or replacement of their implants. These figures do
not include the many patients who have implants inserted for breast
reconstruction after mastectomy.
Medsafe
Information on Implants
American
FDA Information on implants
Implants create three different possible challenges for the
breast surgeon.
First is the assessment of breast symptoms.
Second the challenge of breast screening/ surveillance.
Thirdly the diagnosis and management of specific implant related
problems.
Breast assessment can be difficult in these women.
Clinical examination and mammography are both limited.
The presence of implants should not however delay appropriate
investigation.
Triple assessment consisting of clinical examination, imaging
and biopsy, is required. Ultrasound assisted clinical examination
within the breast centre environment is the ideal way to initiate
assessment. It allows us to distinguish solid from cystic lesions
and the ultrasound findings usually permit categorisation of lumps
as benign, indeterminate or suspicious. It clarifies the position
of the implant relative to the pectoral muscle and gives an
indication of how close the abnormality lies to the implant.
Breast implants are radio-opaque. Mammography is difficult and is
less reliable in this situation as it is not easy to apply
compression or to displace the breast tissue off the implant. If
the presenting complaint is pain or discomfort the patient may be
understandably concerned about the possibility of compression
aggravating her symptoms or rupturing the implant. A
sensitive and well trained radiographer who takes time to explain
things, and demonstrates awareness of the women's concerns can make
a dramatic difference to the quality of the images and the patients
tolerance of the procedure.
Cysts are easily identified and can be drained under ultrasound
guidance. Solid lumps require a biopsy to establish a tissue
diagnosis. Ultrasound guided needle biopsy minimises the risk of
damage to the implant. If excision biopsy or wire localisation is
required it is important to discuss the possibility of damage to
the implant. A pre-operative diagnosis should be obtained whenever
possible to allow optimal planning of the surgical procedure.